{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:24:38Z","timestamp":1785183878586,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Variants in the <jats:italic>PARS2<\/jats:italic> gene have been previously associated with developmental and epileptic encephalopathy. <jats:italic>PARS2<\/jats:italic> deficiency was characterized as a neurodevelopmental and neurodegenerative disorder with early-onset seizures and global developmental delay. Herein, we reported the first case with severe heart failure due to lethal mitochondrial cardiomyopathy with <jats:italic>PARS2<\/jats:italic> compound heterozygous variants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>This patient demonstrated fatigue, chest tightness, and shortness of breath. An acute major illness had been identified at the initial evaluation, which was characterized by severe diaphoresis, dizziness, and fatigue. Blood\u2013urine tandem mass spectrometry found multiple disorders in acid metabolism, characterized as increased homovanillic acid (130.39\u2005mmol\/L) and 2-hydroxyisovaleric acid (1.70\u2005mmol\/L), which are associated with myocardial injuries. Therefore, an inherited metabolic disorder was suspected and whole-exome sequencing was performed, revealing a novel compound heterozygous variant of c.953C&amp;gt;T and c.283G&amp;gt;A on <jats:italic>PARS2<\/jats:italic>. Echocardiography confirmed the findings from the MRI, which presented an increased left ventricular diameter at the end of the diastolic stage. The molecular structure of SYPM was established as AF-Q7L3T8-F1, and the identified mutant sites were located in the proline-tRNA ligase domain. However, the patient died due to severe heart failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the first case to reveal a novel compound heterozygous variant of <jats:italic>PARS2<\/jats:italic>-induced lethal cardiomyopathy with unreversed heart failure. Thus, this report enhances our understanding of mitochondrial tRNA function in maintaining heart function.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1446055","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T04:32:26Z","timestamp":1724646746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: Lethal mitochondrial cardiomyopathy linked to a compound heterozygous variant of\u00a0PARS2"],"prefix":"10.3389","volume":"11","author":[{"given":"Siyuan","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","article-title":"Mitochondrial cardiomyopathies [Review]","volume":"3","author":"El-Hattab","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tma.2023.10.002","article-title":"Mitochondrial cardiomyopathy and emerging therapeutics","volume":"7","author":"Yang","year":"2023","journal-title":"Transl Med Aging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.rec.2014.09.007","article-title":"Mitochondrial cardiomyopathies associated with the m.3243A>G mutation in the gene: two sides of the same coin","volume":"68","author":"Gallego-Delgado","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.3390\/cells11213511","article-title":"Mitochondrial cardiomyopathy: molecular epidemiology, diagnosis, models, and therapeutic management","volume":"11","author":"Yang","year":"2022","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3390\/ijms22115742","article-title":"Molecular epidemiology of mitochondrial cardiomyopathy: a search among mitochondrial and nuclear genes","volume":"22","author":"Mazzaccara","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"102248","DOI":"10.1016\/j.redox.2022.102248","article-title":"Mitochondrial dysfunction by TFAM depletion disrupts self-renewal and lineage differentiation of human PSCs by affecting cell proliferation and YAP response","volume":"50","author":"Qi","year":"2022","journal-title":"Redox Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/circresaha.117.311349","article-title":"Mitochondrial cardiomyopathy caused by elevated reactive oxygen species and impaired cardiomyocyte proliferation","volume":"122","author":"Zhang","year":"2018","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"147985","DOI":"10.1016\/j.gene.2023.147985","article-title":"Novel mutation in PARS2 revealed highly variable phenotype of developmental and epileptic encephalopathy-75","volume":"894","author":"Hu","year":"2024","journal-title":"Gene"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100613","DOI":"10.1016\/j.ymgmr.2020.100613","article-title":"PARS2-associated mitochondrial disease: a case report of a patient with prolonged survival and literature review","volume":"24","author":"Vernon HJ","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2311","DOI":"10.1002\/mgg3.2311","article-title":"Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep","volume":"12","author":"Licchetta","year":"2024","journal-title":"Mol Genet Genomic Med"},{"key":"B11","first-page":"385","article-title":"Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex Heart Inst J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.13054","article-title":"Mitochondrial disease in children","volume":"287","author":"Rahman","year":"2020","journal-title":"J Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11689-019-9292-y","article-title":"Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination","volume":"11","author":"Fine","year":"2019","journal-title":"J Neurodev Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1038\/s41380-021-01207-w","article-title":"PIAS2-mediated blockade of IFN-\u03b2 signaling: a basis for sporadic Parkinson disease dementia","volume":"26","author":"Magalhaes","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2015.01.013","article-title":"The genetic landscape of cardiomyopathy and its role in heart failure","volume":"21","author":"McNally","year":"2015","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.3390\/jcm11216431","article-title":"Mitochondrial cardiomyopathy: the roles of mt-tRNA mutations","volume":"11","author":"Ding","year":"2022","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/genes13071245","article-title":"A novel MTTK gene variant m.8315A>C as a cause of MERRF syndrome","volume":"13","author":"\u0160tufkov\u00e1","year":"2022","journal-title":"Genes (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/b978-0-12-821751-1.00005-1","article-title":"Stroke-like episodes in adult mitochondrial disease","volume":"194","author":"Ng","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5114\/pedm.2021.107713","article-title":"Endocrine disorders in a patient with a suspicion of a mitochondrial disease, MELAS syndrome\u2014a case report and literature review","volume":"27","author":"Baszy\u0144ska-Wilk","year":"2021","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"111979","DOI":"10.1016\/j.ijporl.2024.111979","article-title":"Distribution of mitochondrial MT-RNR1, MT-TL1, MT-TS1, MT-TK and MT-TE genes variants associated with hearing loss in Southwestern China","volume":"181","author":"Zhou","year":"2024","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12920-024-01921-8","article-title":"Increased risk of hearing loss associated with MT-RNR1 gene mutations: a real-world investigation among Han Taiwanese population","volume":"17","author":"Chen","year":"2024","journal-title":"BMC Med Genomics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/cge.12931","article-title":"Novel mutations in KARS cause hypertrophic cardiomyopathy and combined mitochondrial respiratory chain defect","volume":"91","author":"Verrigni","year":"2017","journal-title":"Clin Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/wnl.0000000000000497","article-title":"Novel (ovario) leukodystrophy related to AARS2 mutations","volume":"82","author":"Dallabona","year":"2014","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1161\/circulationaha.123.064489","article-title":"FARS2 deficiency causes cardiomyopathy by disrupting mitochondrial homeostasis and the mitochondrial quality control system","volume":"149","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s10072-021-05626-z","article-title":"Four pedigrees with aminoacyl-tRNA synthetase abnormalities","volume":"43","author":"Okamoto","year":"2022","journal-title":"Neurol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/jhg.2016.163","article-title":"PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder","volume":"62","author":"Mizuguchi","year":"2017","journal-title":"J Hum Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e63589","DOI":"10.1002\/ajmg.a.63589","article-title":"Intracranial calcifications simulating Aicardi-Gouti\u00e8res syndrome in PARS2-related mitochondrial disease","volume":"194","author":"Gerard","year":"2024","journal-title":"Am J Med Genet A"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jmd2.12079","article-title":"Phenotypes and genotypes of mitochondrial aminoacyl-tRNA synthetase deficiencies from a single neurometabolic clinic","volume":"51","author":"Al Balushi","year":"2020","journal-title":"JIMD Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s10038-018-0478-z","article-title":"The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy","volume":"63","author":"Yin","year":"2018","journal-title":"J Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/mgg3.115","article-title":"Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome","volume":"3","author":"Sofou","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11306-018-1370-8","article-title":"A metabolomics-based approach for non-invasive screening of fetal central nervous system anomalies","volume":"14","author":"Troisi","year":"2018","journal-title":"Metabolomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1126\/science.3975630","article-title":"Plasma homovanillic acid concentration and the severity of schizophrenic illness","volume":"227","author":"Davis","year":"1985","journal-title":"Science (New York, NY)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.3390\/biomedicines10123294","article-title":"New insights into the use of empagliflozin\u2014a comprehensive review","volume":"10","author":"Forycka","year":"2022","journal-title":"Biomedicines"},{"key":"B34","doi-asserted-by":"publisher","first-page":"892460","DOI":"10.3389\/fphar.2022.892460","article-title":"Molecular mechanisms of sacubitril\/valsartan in cardiac remodeling","volume":"13","author":"Mustafa","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1446055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T04:32:30Z","timestamp":1724646750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1446055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2024.1446055"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1446055","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"article-number":"1446055"}}